Currently, Nyloxin is available as an oral spray to treat back pain, neck aches, headaches, joint pain, migraines, and neuralgia, and as a topical gel for treating joint pain, neck pain, arthritis pain and pain from repetitive stress in the US.
Nutra Pharma chairman and CEO Rik Deitsch said they are excited to be working with Alampharm to introduce their Nyloxin products into Lebanon.
Alampharm CEO Khaled Alam said Nyloxin will be promoted through professional medical representatives to orthopedics, neurologists, and oncologists and they will position Nyloxin as the first choice treatment of chronic pain management.